Alec Stranahan
Stock Analyst at B of A Securities
(0.92)
# 1749
Out of 5,240 analysts
28
Total ratings
33.33%
Success rate
16.22%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Day One Biopharmaceu... | Maintains: Buy | 28 25 | 11.54 | 116.64% | 4 | Jan 7, 2025 | |
Caribou Biosciences | Maintains: Buy | 13 11 | 1.6 | 587.5% | 1 | Jan 7, 2025 | |
Erasca | Upgrades: Buy | 5 5 | 1.97 | 153.81% | 2 | Jan 7, 2025 | |
Perspective Therapeu... | Downgrades: Neutral | 24 6 | 3.17 | 89.27% | 2 | Nov 25, 2024 | |
Revolution Medicines | Maintains: Strong Buy | 48 55 | 40.27 | 36.58% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 18 | 8.84 | 103.62% | 3 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 118 140 | 147.29 | -4.95% | 3 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 42 | 19.64 | 113.85% | 1 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 12 | 6.58 | 82.37% | 4 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 5 6 | 30.66 | -80.43% | 2 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 60 5 | 1.87 | 167.38% | 1 | Dec 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | 32.24 | 39.58% | 1 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 58 | n/a | n/a | 1 | May 20, 2022 |